Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Anzhen Street No.2 Chaoyang District, Beijing, 100029, China.
J Cardiothorac Surg. 2020 Aug 20;15(1):223. doi: 10.1186/s13019-020-01261-5.
The efficacy of intra-aortic balloon pump (IABP) has been proven in high-risk patients undergoing coronary artery bypass grafting (CABG). However, data on the timing and benefits of IABP support in diffuse coronary artery disease after CABG combined with coronary endarterectomy (CE) remain scarce. This retrospective study assessed the effect of intraoperative or postoperative IABP on 30-day outcomes of off-pump CABG+CE.
From January 2012 to December 2018, 546 patients undergone off-pump CABG+CE were divided into control group (n = 437) and IABP group (n = 109). Risk factors for 30-day outcomes were evaluated. Subgroup analysis from IABP group was conducted to identify the effect of timing IABP on 30-day outcomes.
CE on left anterior descending branch of coronary artery (LAD) (OR = 3.079, 95% CI 1.077-8.805, P = 0.036), CE with≥2 vessels (OR = 9.123, 95% CI 3.179-26.033, P < 0.001) and length of atherosclerotic plaque ≥3 cm (OR = 16.017, 95% CI 5.941-43.183, P < 0.001) were independent risk factors for postoperative acute myocardial infarction (AMI) and 30-day mortality. Comparing with intraoperative IABP support, postoperative IABP support (OR = 3.987, 95% CI1.194-13.317, P = 0.025) was closely associated with postoperative AMI and 30-day mortality.
For patients undergone off-pump CABG and extensive CE (CE on LAD, CE ≥2 vessels and length of atherosclerotic plaque ≥3 cm), intraoperative IABP support may improve 30-day outcomes.
主动脉内球囊反搏(IABP)在高危行冠状动脉旁路移植术(CABG)的患者中的疗效已得到证实。然而,关于 CABG 联合冠状动脉内膜切除术(CE)后弥漫性冠状动脉疾病中 IABP 支持的时机和益处的数据仍然很少。本回顾性研究评估了非体外循环 CABG+CE 术中或术后使用 IABP 对 30 天结果的影响。
从 2012 年 1 月至 2018 年 12 月,546 例行非体外循环 CABG+CE 的患者分为对照组(n=437)和 IABP 组(n=109)。评估了 30 天结果的危险因素。对 IABP 组进行亚组分析,以确定 IABP 时机对 30 天结果的影响。
CE 在左前降支冠状动脉(LAD)(OR=3.079,95%CI 1.077-8.805,P=0.036)、CE 伴≥2 支血管(OR=9.123,95%CI 3.179-26.033,P<0.001)和粥样斑块长度≥3cm(OR=16.017,95%CI 5.941-43.183,P<0.001)是术后急性心肌梗死(AMI)和 30 天死亡率的独立危险因素。与术中 IABP 支持相比,术后 IABP 支持(OR=3.987,95%CI 1.194-13.317,P=0.025)与术后 AMI 和 30 天死亡率密切相关。
对于行非体外循环 CABG 和广泛 CE(CE 在 LAD、CE≥2 支血管和粥样斑块长度≥3cm)的患者,术中 IABP 支持可能改善 30 天结果。